Sutro Biopharma, Inc. (STRO)
9.33
-0.96
(-9.33%)
USD |
NASDAQ |
Oct 23, 16:00
9.335
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma EPS Diluted (Quarterly) : -2.325 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.325 |
| March 31, 2026 | -2.942 |
| December 31, 2025 | -5.447 |
| September 30, 2025 | -6.699 |
| June 30, 2025 | -1.360 |
| March 31, 2025 | -0.9141 |
| December 31, 2024 | -8.778 |
| September 30, 2024 | -0.5946 |
| June 30, 2024 | -0.5912 |
| March 31, 2024 | -0.9472 |
| December 31, 2023 | 0.5092 |
| September 30, 2023 | -0.8133 |
| June 30, 2023 | -0.6384 |
| March 31, 2023 | -0.8523 |
| December 31, 2022 | -0.6092 |
| September 30, 2022 | -0.3723 |
| June 30, 2022 | -0.554 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.8411 |
| December 31, 2021 | -0.823 |
| September 30, 2021 | -0.6694 |
| June 30, 2021 | -0.1334 |
| March 31, 2021 | -0.6613 |
| December 31, 2020 | -1.48 |
| September 30, 2020 | 0.4525 |
| June 30, 2020 | 0.94 |
| March 31, 2020 | -0.8447 |
| December 31, 2019 | -0.6402 |
| September 30, 2019 | -0.5627 |
| June 30, 2019 | -0.6016 |
| March 31, 2019 | -0.6232 |
| December 31, 2018 | -0.0653 |
| September 30, 2018 | -0.448 |
| December 31, 2017 | -6.716 |
| September 30, 2017 | -0.0621 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Upstream Bio, Inc. | -0.7276 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.53M |
| Revenue (Quarterly) | 9.839M |
| Total Expenses (Quarterly) | 48.37M |
| Enterprise Value | 240.16M |
| Gross Profit Margin (Quarterly) | 87.17% |
| Profit Margin (Quarterly) | -391.6% |
| Earnings Yield | -186.6% |
| Normalized Earnings Yield | -174.24 |